Dr. Andrew B. Dickerson
Pediatric Gastroenterology (Pediatric Gastroenterology Physician)
3030 Childrens Way
San Diego, CA 92123
Who else practices at this address →
San Diego County includes primary care (1% of residents) and mental health (1% of residents) shortage areas. About shortage areas
At a glance
- Medical school
- University of Tennessee, Hsc, College of Medicine (2014)
- Years since graduation
- 12
- In the NPI registry since
- 2018
Licensed in California since 2019, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2014Medical school: University of Tennessee, Hsc, College of Medicine
- 2018Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pediatric Gastroenterology Physician primary
CA license A164904 (first issued 2019; current) -
Pediatrics Physician
CA license A164904 (first issued 2019; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Rady Children's Hospital San Diego (169 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Payments from drug and device companies
In 2025, 5 companies reported 20 payments worth $37,839 in total to this clinician.
| Genzyme Corporation | $32,103 |
|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $3,723 |
| Regeneron Healthcare Solutions, Inc. | $1,978 |
| Alcresta Therapeutics, Inc. | $20.21 |
| Qol Medical, LLC | $14.81 |
| Compensation for services other than consulting (speaking, faculty) | $28,502 |
|---|---|
| Travel and Lodging | $5,089 |
| Consulting Fee | $3,509 |
| Food and Beverage | $739 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Genzyme Corporation Feb 6, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $7,329 |
| Genzyme Corporation Apr 14, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $7,329 |
| Genzyme Corporation Jun 25, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $5,933 |
| Genzyme Corporation Feb 13, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $5,933 |
| Takeda Pharmaceuticals U.S.A., Inc. Jan 9, 2025 | Consulting Fee EOHILIA · INTERNAL MEDICINE | $2,174 |
| Regeneron Healthcare Solutions, Inc. Mar 14, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $1,978 |
| Genzyme Corporation Feb 13, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Redlands, CA · in-kind | $1,380 |
| Genzyme Corporation Feb 6, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Beverly Hills, CA · in-kind | $1,370 |
| Takeda Pharmaceuticals U.S.A., Inc. Apr 16, 2025 | Consulting Fee EOHILIA · INTERNAL MEDICINE | $1,335 |
| Genzyme Corporation Apr 14, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Beverly Hills, CA · in-kind | $1,271 |
All 11 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Genzyme Corporation Jun 25, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $5,933 |
| Genzyme Corporation Jun 25, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Anaheim, CA · in-kind | $1,067 |
| Takeda Pharmaceuticals U.S.A., Inc. Apr 16, 2025 | Consulting Fee EOHILIA · INTERNAL MEDICINE | $1,335 |
| Genzyme Corporation Apr 14, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $7,329 |
| Genzyme Corporation Apr 14, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Beverly Hills, CA · in-kind | $1,271 |
| Regeneron Healthcare Solutions, Inc. Mar 14, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $1,978 |
| Genzyme Corporation Feb 13, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $5,933 |
| Genzyme Corporation Feb 13, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Redlands, CA · in-kind | $1,380 |
| Genzyme Corporation Feb 6, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $7,329 |
| Genzyme Corporation Feb 6, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Beverly Hills, CA · in-kind | $1,370 |
| Takeda Pharmaceuticals U.S.A., Inc. Jan 9, 2025 | Consulting Fee EOHILIA · INTERNAL MEDICINE | $2,174 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.